Chunlan Pu
Impact in
-
- Peptidase Inhibition and Analysis
-
- Multiple Myeloma Research and Treatments
Papers in
-
- Protein Degradation and Inhibitors 13
- Ubiquitin and proteasome pathways 9
- Histone Deacetylase Inhibitors Research 3
- Oncology 11
- Peptidase Inhibition and Analysis 7
- PARP inhibition in cancer therapy 3
- Co-authors
- Rui Li (13 shared papers)Guoyi Yan (14 shared papers)Suke Lan (9 shared papers)Shirui Wang (10 shared papers)Xueyan Hou (9 shared papers)Xinyu Ma (9 shared papers)Meng Zhou (6 shared papers)Hongjia Zhang (5 shared papers)
- Journals
- European Journal of Medicinal Chemistry (9 papers)Bioorganic & Medicinal Chemistry (3 papers)Journal of Medicinal Chemistry (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)MedChemComm (2 papers)
- Partner nations
- ChinaNetherlandsGermany
In The Last Decade
Chunlan Pu
30 papers receiving 429 citations
Peers
Comparison fields: 5 of 62
- Oncology 136
- Hematology 54
- Molecular Biology 285
- Transplantation 7
- Pulmonary and Respiratory Medicine 81
Countries citing papers authored by Chunlan Pu
This map shows the geographic impact of Chunlan Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunlan Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunlan Pu more than expected).
Fields of papers citing papers by Chunlan Pu
This network shows the impact of papers produced by Chunlan Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunlan Pu. The network helps show where Chunlan Pu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chunlan Pu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 52 | |
| 2 | 2021 | 41 | |
| 3 | 2022 | 34 | |
| 4 | 2017 | 32 | |
| 5 | 2016 | 30 | |
| 6 | 2023 | 24 | |
| 7 | 2009 | 23 | |
| 8 | 2023 | 20 | |
| 9 | 2024 | 19 | |
| 10 | 2022 | 17 | |
| 11 | 2022 | 14 | |
| 12 | 2024 | 14 | |
| 13 | 2022 | 14 | |
| 14 | 2019 | 13 | |
| 15 | 2017 | 12 | |
| 16 | 2021 | 12 | |
| 17 | 2024 | 9 | |
| 18 | 2021 | 9 | |
| 19 | 2024 | 8 | |
| 20 | 2017 | 6 |
About Chunlan Pu
Chunlan Pu is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 32 papers that have together received 434 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (13 papers), Ubiquitin and proteasome pathways (9 papers), Peptidase Inhibition and Analysis (7 papers), HIV Research and Treatment (3 papers), Synthesis and biological activity (3 papers), PARP inhibition in cancer therapy (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Oncology (136 citations), Hematology (54 citations), Molecular Biology (285 citations), Transplantation (7 citations) and Pulmonary and Respiratory Medicine (81 citations). Chunlan Pu has collaborated with scholars based in China, Netherlands and Germany. Frequent co-authors include Rui Li, Guoyi Yan, Suke Lan, Shirui Wang, Xueyan Hou, Xinyu Ma, Meng Zhou, Hongjia Zhang, Dan Luo and Rui Deng. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and MedChemComm.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.